JAMDA15(2014)873e880
JAMDA
journal homepage: www.jamda.com
Original Study
The Study of Mental and Resistance Training (SMART)
StudydResistance Training and/or Cognitive Training
in Mild Cognitive Impairment: A Randomized, Double-Blind,
Double-Sham Controlled Trial
Maria A. Fiatarone Singh MDa,b,c,*, Nicola Gates PhDd, Nidhi Saigal MPHe,
Guy C. Wilson MSe, Jacinda Meiklejohn BSe, Henry Brodaty MBBSf, Wei Wen PhDf,g,
Nalin SinghMBBSh,i,BernhardT.BaunePhDj,ChaoSuo PhDk,MichaelK.Baker PhDe,l,
Nasim Foroughi PhDm, Yi Wang PhDn, Perminder S. Sachdev PhDf,g,
Michael Valenzuela PhDo
aExercise,HealthandPerformanceFacultyResearchGroup,FacultyofHealthSciences,SydneyMedicalSchool,TheUniversityofSydney,Lidcombe,New
SouthWales,Australia
bHebrewSeniorLife,Boston,MA
cJeanMayerUSDAHumanNutritionResearchCenteronAgingatTuftsUniversity,Boston,MA
dPrivateNeuropsychologyPractice,Mosman,NewSouthWales,Australia
eExerciseHealthandPerformance,FacultyofHealthSciences,UniversityofSydney,Lidcombe,NewSouthWales,Australia
fSchoolofPsychiatry,UniversityofNewSouthWales,Sydney,NewSouthWales,Australia
gCenterforHealthyBrainAgeing(CHeBA),NPI,EuroaCentre,PrinceofWalesHospital,Randwick,NewSouthWales,Australia
hRoyalPrinceAlfredandBalmainHospitalBalmainHospital,Balmain,NewSouthWales,Australia
iRoyalPrinceAlfredHospital,Camperdown,NewSouthWales,Australia
jDepartmentofPsychiatry,SchoolofMedicine,UniversityofAdelaide,Adelaide,SouthAustralia,Australia
kMonashClinicalandImagingNeuroscience,SchoolofPsychologyandPsychiatry,MonashUniversity,Clayton,Victoria,Australia
lAustralianCatholicUniversity,NewSouthWales,Australia
mClinicalandRehabilitationResearchGroup,FacultyofHealthSciences,TheUniversityofSydney,Lidcombe,NewSouthWales,Australia
nDepartmentofMedicineandtheDiabetesCenter,UniversityofCaliforniaatSanFrancisco,SanFrancisco,CA
oRegenerativeNeuroscienceGroup,BrainandMindResearchInstitute,TheUniversityofSydney,Camperdown,NewSouthWales,Australia
a b s t r a c t
Keywords: Background:Mildcognitiveimpairment(MCI)increasesdementiariskwithnopharmacologictreatment
Mildcognitiveimpairment available.
resistancetraining Methods: TheStudyofMentaland ResistanceTrainingwasarandomized, double-blind, double-sham
cognitivetraining
controlledtrialofadultswithMCI.Participantswererandomizedto2supervisedinterventions:activeor
shamphysicaltraining(highintensityprogressiveresistancetrainingvsseatedcalisthenics)plusactive
orshamcognitivetraining(computerized,multidomaincognitivetrainingvswatchingvideos/quizzes),
2e3days/weekfor6monthswith18-monthfollow-up.Primaryoutcomeswereglobalcognitivefunction
(Alzheimer’s Disease Assessment Scale-cognitive subscale; ADAS-Cog) and functional independence
(BayerActivitiesofDailyLiving).Secondaryoutcomesincludedexecutivefunction,memory,andspeed/
attentiontests,andcognitivedomainscores.
Registry Protocol No: X08-0064 (Australian and New Zealand Clinical Trials MV has previously received speaking honoraria and research funding from
Registry;http://www.anzctr.org.au) PfizerNeuroscienceandTheBrainDepartmentPtyLtd.Hecurrentlyreceivesin-
This study was funded by a National Health and Medical Research Council kindresearchsupportfromBrainTrainInc.forworkunrelatedtothisreport.HB
(NH&MRC)ofAustraliaDementiaResearchGrant,projectgrantIDNo.512672from hasbeenaninvestigatorforPfizer,Novartis,Janssen,Lilly,Mediation,Sanofiand
2008-2011(https://www.nhmrc.gov.au).Additionalfundingforaresearchassistant Servier;asponsoredspeakerforPfizer,Novartis,JanssenandLundbeck;andison
positionwas sourced from the NHMRC Program Grant ID No. 568969, and the advisoryBoardsforPfizer,Novartis,Janssen,Lundbeck,MerckandBaxter.BBisa
projectwassupportedbytheUniversityofSydneyandUniversityofNewSouth memberofadvisoryboardsand/orgavepresentationsforthefollowingcompanies,
Wales.Thefundershadnoroleinstudydesign,datacollectionandanalysis,de- forwhichhehasreceivedhonoraria:AstraZeneca,Lundbeck,Pfizer,Servier,and
cisiontopublish,orpreparationofthemanuscript.MVwassupportedbyaUni- Wyeth.
versityofNewSouthWalesViceChancellor’sFellowshipandaNHMRCClinical * AddresscorrespondencetoMariaA.FiataroneSingh,MD,Exercise,Healthand
Career Development Fellowship (1004156). This work fulfilled a portion of the Rehabilitation Faculty Research Group, Faculty of Health Sciences, University of
degreerequirementsforPhDforNicolaGatesandChaoSuo. Sydney,75EastStreet,Lidcombe,NSW2141,Australia.
Theauthorsdeclarenoconflictsofinterest. E-mailaddress:maria.fiataronesingh@sydney.edu.au(M.A.FiataroneSingh).
http://dx.doi.org/10.1016/j.jamda.2014.09.010
1525-8610/(cid:1)2014AMDAeTheSocietyforPost-AcuteandLong-TermCareMedicine.
874 M.A.FiataroneSinghetal./JAMDA15(2014)873e880
Results: One hundred adults with MCI [70.1 (6.7) years; 68% women] were enrolled and analyzed.
Resistance training significantly improved the primary outcome ADAS-Cog; [relative effect size (95%
confidenceinterval)(cid:1)0.33((cid:1)0.73,0.06);P<.05]at6monthsandexecutivefunction(WechslerAdult
IntelligenceScaleMatrices;P¼.016)across18months.NormalADAS-Cogscoresoccurredin48%(24/49)
afterresistancetrainingvs27%(14/51)withoutresistancetraining[P<.03;oddsratio(95%confidence
interval)3.50(1.18,10.48)].CognitivetrainingonlyattenuateddeclineinMemoryDomainat6months
(P<.02).Resistancetraining18-monthbenefitwas74%higher(P¼.02)forExecutiveDomaincompared
with combined training [z-score change ¼ 0.42 (0.22, 0.63) resistance training vs 0.11 ((cid:1)0.60, 0.28)
combined]and48%higher(P<.04)forGlobalDomain[z-scorechange¼.0.45(0.29,0.61)resistance
trainingvs0.23(0.10,0.36)combined].
Conclusions:Resistancetrainingsignificantlyimprovedglobalcognitivefunction,withmaintenanceof
executiveandglobalbenefitsover18months.
(cid:1)2014AMDAeTheSocietyforPost-AcuteandLong-TermCareMedicine.
Dementia presents a major challenge to individuals, their care- independenceoffunctionasassessedbytheBayerActivitiesof
givers,andthehealthcaresystemglobally,with135millionpersons Daily Living Scale (BAYER-ADL)21 at both 6- and 18-month
projected to be affected by 2050.1 Thus, delay of dementia onset, follow-up,relative tosham cognitiveandshamexercise con-
progression,andseverityareamongthemostpressingchallengesfor trolconditions,respectively.
medical research today. Mild cognitive impairment (MCI) is a diag- (2) Both CT and PRT would significantly improve secondary
nostictermappliedtoindividualsintheintermediatestagebetween cognitive outcomes across memory, executive function, and
normal cognitive function and dementia.2 MCI increases the risk Attention/SpeedDomains.
fordementia,with diagnosed individuals progressing at rates upto (3) ThecombinationofCTandPRTwouldbesignificantlysuperiorto
6%e10%peryearcomparedwith1%e2%inthegeneralpopulation.3 eitherinterventionaloneforcognitiveandfunctionalbenefits.
Pharmacologic treatments for dementia4 have not been effective in
MCI for either cognitive improvement or reduction of incident de- Methods
mentia or its severity. Therefore, nonpharmacologic investigations
addressingcognitivedeclineareurgentlyrecommended.5 StudyDesignandSetting
Thereisstrongevidencefromcross-sectional,prospectivecohort,
and experimental studies that participation in mentally and physi- ThefullprotocolfortheSMARTtrialhasbeenpublished,19andthe
cally stimulating activities is associated with decreased dementia protocol registered with the Australian New Zealand Clinical Trials
prevalenceand/orincidenceaswellasimprovedcognitivefunctionin RegistryProtocolNo:X08-0064(ANZCTR;http://www.ansctr.org.au).
healthyindividualsandsomeclinicalcohorts.6e8Ourmeta-analysis9
TheSMARTtrialisarandomized,fully-factorial,double-blind,double
andreviewofpublishedrandomizedcontrolledtrials(RCTs)inolder sham training-controlled clinical trial adhering closely to Consoli-
adults10suggesteffectsizesforcognitiveoutcomesofapproximately dated Standards of Reporting Trials guidelines for the conduct and
0.60 for cognitive training (CT), 0.59 for aerobic/resistance training, reporting of clinical trials, as extended to nonpharmacologic
and 0.53 for resistance training, compared with 0.15 for healthy interventions.
controlgroups.However,theevidenceforefficacyofanyintervention
inthosewithMCIislesscertain.Forexample,inoursystematicre- StudyPopulationandEligibilityCriteria
view of cognitive outcomes in 14 RCTs of exercise specifically in
MCI,1142% of effect sizes were potentially clinically relevant (effect Participantswerecommunity-dwellingmenandwomenaged55
size >0.20), but only 8% statistically significant. Similarly, in our orabovewithMCIdiagnosis,consistentwiththePetersencriteria.22
systematicreviewof10cognitive/memorytrainingtrialsinMCI,12
only 3 of the 5 RCTs had significant effects, limited to memory. InterventionArms
Further, robustly designed trials with longitudinal follow-up have
beenrecommendedinMCItoinvestigatethecomparativebenefitsof Complete intervention details have been published19 and are
isolatedandcombinedphysicalandmentaltraining. summarizedbelow.
Progressive resistance training (PRT) has been studied far less
extensively than aerobic training in MCI. However, the potential DoseandSupervision
utilityof PRT is suggested by its beneficial effects on insulin-like
growth factor-1, insulin sensitivity, and anti-inflammatory and All training was fullysupervisedby research assistants from ex-
brain-derived neurotrophic factor pathways, which are related to ercise physiology or physical therapy backgrounds. Initial training
both sarcopeniaand cognitive decline,13,14the observed positive ef- frequencyof3days/weekwasreducedto2days/weekafterthefirst
fectsofhigher muscle/lean massoncognition15and brain size,16as 30 participants to minimize burden/transportation difficulties. Each
wellasasmallnumberofpositiveclinicaltrials.11,17,18Therefore,we sessiontookapproximately60e100minutesonaverage(60minutes
designed the Study of Mental Activity and Resistance Training control, 75 minutes PRT, or CTgroups,100 minutes combined), but
(SMART)trial19toexaminetheisolatedandcombinedbenefitsofCT varied according to the physical frailty or level of cognitive impair-
andresistancetraininginMCI. mentineachparticipant.
Wehypothesizedthefollowing:
CTIntervention(þShamExercise)
(1) Six months of supervised CT or PRT would significantly
improve global cognitive function in older adults with MCI, CT intervention involved computer-based multimodal and
asassessedbyourprimaryoutcome:theAlzheimer’sDisease multidomain exercises targeting memory, executive function, atten-
Assessment Scale-Cognitive subscale (ADAS-Cog)20 and tion, and speed of information processing. The training used the
M.A.FiataroneSinghetal./JAMDA15(2014)873e880 875
COGPACKprogram,23developedforneuro-rehabilitationandusedina assessed via the ADAS-Cog, and mental capacity to perform daily
previousresearchtrialwithMCI,whichnoparticipanthadusedbefore. tasksbytheBayerActivitiesofDailyLiving(B-IADL),whichhasbeen
Fourteenprogressivelymoredifficultexerciseswereselectedincluding found to differentiate between normal aging and mild to moderate
6 tasks of visual and verbal explicit memory, advancing to a more dementia.Scores (cid:3)5 on the ADAS-Cog (the mean score reported in
difficulttaskeachsession.Trainingsessionswerecompletedinasu- noncognitivelyimpairedvolunteersages55to89)werecategorized
pervisedgroupsettingwithupto10computerworkstationsandsimple asnormal.
touchscreenstoavoidtrainingdifficultiesinthecomputer-naïve.
SecondaryCognitiveOutcomes
PRT(þShamCognitive)
Executive function was assessed by Matrices and Similarities
PRT was supervisedbyexperienced research assistants(exercise
subtestsoftheWechslerAdultIntelligenceScale3rdEdition(WAIS-
physiologistsandphysiotherapists)inaphysician-supervisedclinicat III) and verbal fluency (Controlled Oral Words Association Test
theUniversityofSydneyExercisecampusataratioof1trainer:4e5
(COWAT) and Animal Naming). Memory tests included auditory
participants. Pneumatic resistance machines (Keiser Sports Health
Logical Memory I (immediate) and II (delayed) subtests of the
Equipment,Ltd)wereusedfortrainingathighintensity,3setsof8 WechslerMemoryScale3rdEdition(WMS-III)25andtheListLearning
repetitions of each of 5e6 exercises/session for most major muscle
subsectionof theADAS-Cog,andvisualviaBentonVisualRetention
groups (chest press, leg press, seated row, standing hip abduction,
Test-Revised5thEdition(BVRT-R).Attention/speedwasassessedvia
kneeextension).
SymbolDigitModalitiesTest(SDMT).CognitiveDomainscoreswere
calculatedbycreatingandthenaveragingthez-scoresofcomponent
CombinedCTandPRT tests at each time point, referenced to whole-group baseline mean
andstandarddeviation.GlobalDomainincludedalltestsexceptList
This group received both the CT intervention and PRT Learning, as it was already included within ADAS-Cog total score.
interventionsasabovesequentiallyduringthesamesession. ExecutiveDomainincludedWAISSimilaritiesandMatrices,COWAT,
andAnimalNaming.MemoryDomainincludedLogicalMemoryIand
Control II,ListLearning,andBVRT-R.
Thecontrol group received both shamcognitiveand shamexer-
Randomization,Stratification,Concealment,andAllocation
ciseinterventions.
A concealed, computer-generated sequence of randomly
ShamCognitive
permutedblocks(blocksize¼8)ina1:1:1:1ratiotoeachofthe4
intervention arms,stratified bysex and age(<75 and 75 þ years),
ShamCT(shamcognitive)consistedofwatching5shortNational
wasgeneratedbyaresearchassistantnototherwiseinvolvedinthe
Geographic videos, followed by a set of 15 questions (3/video)
study via a statistical website (www.randomization.com created by
regarding the presented material, as has been used in previous tri-
Dr.GerardE.Dallal,TuftsUniversity)atthecompletionofallbaseline
als24withminimalimpactoncognitiveoutcomes.Feedbackwasnot
assessments.Assignmentswerethenplacedinsealedopaqueenve-
providedunlessrequestedspecifically.
lopesanddeliveredtoparticipantsbytherecruitmentofficer.
ShamExercise
Results
Thisgroupperformedstretchingandseatedcalisthenicsdesigned
so as not to notably increase heart rate or aerobic capacity, nor RecruitmentandRetention
improvebalance,enhancestrength,orotherphysiologicaloutcomes.
AsshowninFigure1,fromthe2094peoplecontacted(primarily
AdverseEvents viaelectoralroll),themajoritywerenotinterested/didnotrespond
(76%)orineligible(3%)aftertelephonescreening,orplacedonhold
Adverse eventsweredefined a priori as anyexacerbation of un- primarily for being too physically active (10%). Notably, among the
derlying disease, or new onset musculoskeletal, cardiovascular, or 135individualsdiagnosedwithMCI,75%(100)wereinterestedand
metabolic abnormalityattributed directly to study protocols. Moni- enrolled.Dropoutratewasmuchlowerthanexpected(8%and12%at
toringofadverseeventsover18monthswasdoneprospectivelyby 6and18months,respectively)becauseofcommitment(5%),dissat-
weekly questionnaire/interview with proxy information obtained
isfaction(3%),orhealth(4%)issues.Sixpercent(n¼6)discontinued
whenevernecessary. training, all because of commitment issues, not health or adverse
events.
OutcomeAssessments
TrainingAdherenceandFidelity
Blindedassessorsadministeredalloutcomemeasuresatbaseline,
6and18months.Cognitivetestingtookplaceatleast72hoursafter Therewerenogroupdifferencesinthemediantrainingduration
the previous training session, in a fed state (after breakfast), and of 26 (0e28) weeks. Absolute exercise adherence (number of ses-
beforeanyphysicaltestingonthatdaytostandardizeknowneffects sions)wasequivalentbetweenPRTandshamexercise:mean(stan-
offastingandacuteexerciseoncognitiveperformance. darddeviation)42(19)vs42(20);P¼.96).Theintendedincreasein
totaltonnage(totalweightlifted)over6monthsaveraged48(49%),
PrimaryOutcomes with a nonsignificantly greater increase in the Combined Training
GroupthanisolatedPRT[56(46%)vs38(51%),respectively,P¼.21].
DetailsofcognitiveassessmentsarepresentedinSupplementary Absolute cognitive session adherence was higher in CT than sham
Table 1 and the published protocol.19 Global cognitivefunctionwas cognitive:[52(19)vs42(22);P¼.02].
876 M.A.FiataroneSinghetal./JAMDA15(2014)873e880
respectively) in the proportion with normal ADAS-Cog scores after
training[P>.99;adjustedOR1.00(0.34,2.90].
Functionalindependence:BAYER-ADL
Functionalimpairmentwasminimalatbaseline(consistentwith
MCIcriteria)andimprovedslightlyovertime(P<.001),asshownin
Tables1and2,withoutgroupeffects.
SecondaryCognitiveOutcomes
SecondaryoutcomesarepresentedinTables1and2.
ExecutiveFunction
Resistancetrainingsignificantlyimprovedexecutivefunctiontest
WAIS Matrices (P < .02) with trend for improvement in overall
Executive Domain score as well (P < .07), both over 18 months
(Tables1and2).Bycontrast,therewasnosignificanteffectofCTon
ExecutiveDomain.
Contrarytoourhypothesis,theCombinedGroupdidnotperform
better than the single intervention arms. Instead, there was a sig-
nificant RESISTANCE (cid:4) COGNITIVE (cid:4) TIME interaction term in the
mixedmodelsforbothCategoryFluency(AnimalNaming;P<.02and
P ¼.003 over6 and 18 months, respectively),as well as foroverall
ExecutiveDomain(P¼.01and<.02over6and18months,respec-
tively),seeTables1and2.ThisinteractionwasduetothePRTGroup
improving60%morethantheCombinedGrouponExecutiveDomain
Fig.1. Flowofparticipantsthroughthestudy.Participantswererandomizedinto1of4
treatmentgroupsina fullyfactorialdesign sothatall participants receivedeither changesat6months[meanz-scorechangeof0.426(0.249,0.603)vs
activeorshamcognitiveinterventionpluseitheractiveorshamexerciseintervention. 0.168 (0.026, 0.310), respectively, P < .03]. The Executive Domain
CT(þshamexercise)¼Computerizedcognitivetrainingplusstretchingexercise;PRT
difference between PRT Group [mean z-score change 0.424 (0.215,
(þsham COG) ¼ Progressive resistance training plus video watching; Combined
0.632)] and the Combined Group [mean z-score change 0.109
(CTþPRT)¼Computerizedcognitivetrainingplusprogressiveresistancetraining;
Control(shamCOGþshamexercise)¼videowatchingplusstretchingexercise
((cid:1)0.060,0.278)]wasevengreaterat18months,withthePRTbenefit
74%higherthantheCombinedGroup(P¼.02),(Figure3a).
AdverseEvents
Memory
Therewere6adversemusculoskeletaleventsover18months(3
fallsduringassessmentsand3exacerbationsofpre-existingarthritis Theeffectsofresistancetrainingonmemoryweremixed.Resis-
symptoms during strength testing/training, with 1 unresolved tancetrainingattenuatedthedeclineinvisual/constructional mem-
(exacerbationofanunderlyingrotatorcufftear). ory(BVRT-R;P¼.04)butwasassociatedwithworsedelayedauditory
memory at 6 months (P < .03) and had no significant effect on
Participants MemoryDomainscore;seeTables1and2.Ontheotherhand,CTdid
notsignificantlyimproveanyindividualmemorytest,butmaintained
Baseline characteristics of participants are shown in the Memory Domain z-score (þ0.036) compared with z-score de-
Supplementary Table2;therewereno significantgroup differences clineswithoutCT((cid:1)0.196)at6months[z-scoremeandifference0.23
(P>.05).All 100 participants and93%of theirinformants reported ((cid:1)0.06,0.52);P¼.01].
concernover memory/cognitivedecline.Themost commonchronic
conditions were osteoarthritis (73%), hypertension (42%), hyperlip- Speed/Attention
idemia(30%),osteoporosis(21%),diabetes(11%),andcoronaryartery
disease(6%). All participants improved slightly but significantly over time,
withoutgroupeffects(Tables1and2).
PrimaryOutcomes
GlobalFunctionDomain
Globalcognition:ADAS-Cog
Primary outcomes (ADAS-Cog and BAYER-ADL) are reported in There was a very small but significant improvement in Global
Tables1and2.ResistancetrainingsignificantlyimprovedADAS-Cog Domain in the whole cohort over 6 months, with no group
comparedwithshamexercise(P<.05)over6months,withatrend differences [mean z-score change 0.119 (0.055, 0.183); P < .001,
for benefit persistent over 18 months (P ¼.08). The proportion of Tables1and2].SimilartothefindingsforbothCategoryFluencyand
participants with normal ADAS-Cog scores after resistance training Executive Domain above, there was a trend for an interaction of
doubledfrom24%to48%(absoluteincreaseof24%),comparedwith RESISTANCE (cid:4) COGNITIVE (cid:4) TIME over 18 months (P < .07). As
an increase from 20% to 27% (absolute increase of 7%) with sham shown in Figure 3b, this was due to the PRT Group having a 48%
exercise[P<.03;adjustedoddsratio(OR;95%confidenceintervals) higherbenefit[meanz-scorechange0.452(0.291,0.614)]compared
3.50; (1.18, 10.48)]; Figure 2. By contrast, there was no difference withtheCombinedGroup[meanz-scorechange0.233(0.103,0.363)]
between CT and sham cognitive (absolute increase of 19% vs 13%, onGlobalDomainchangesat18months(P<.04).
M.A.FiataroneSinghetal./JAMDA15(2014)873e880 877
Table1
MeanScores(95%CIs)forPrimaryOutcomesatallTimePointsforEachRandomizationGroup
OutcomeMeasures RandomizationGroup
TimePoint CT(þsham PRT(þsham Combined(CTþPRT) Control(Sham
Exercise) Cognitive) Cognitiveþ
ShamExercise)
Globalcognition
ADAS-Cog* Baseline 8.79(7.57,10.02) 8.29(7.02,9.56) 8.02(6.87,9.17) 8.09(6.95,6.93)
6months 7.31(6.08,8.54) 5.56(4.2,6.91) 6.26(5.11,7.41) 7.14(5.97,8.30)
18months 6.49(5.24,7.75) 4.97(3.55,6.38) 5.76(4.59.6.92) 5.75(4.58,6.93)
GlobalCognitionDomain Baseline (cid:1)0.044((cid:1)0.276,0.187) 0.082((cid:1)0.159,0.323) (cid:1)0.077((cid:1)0.295,0.141) (cid:1)0.113((cid:1)0.330,0.104)
6months 0.109((cid:1)0.247,0.342) 0.259((cid:1)0.010,0.509) 0.072((cid:1)0.146,0.290) (cid:1)0.116((cid:1)0.335,0.103)
18months 0.312(0.077,0.548) 0.536(0.279,0.794) 0.165((cid:1)0.055,0.385) 0.108((cid:1)0.113,0.328)
ExecutiveFunction
WAIS-IIISimilarities Baseline 19.11(17.28,20.95) 19.83(17.92,21.74) 19.05(17.32,20.77) 17.84(16.12,19.56)
6months 21.52(19.67,23.37) 22.35(20.31,24.39) 20.57(18.84,22.29) 19.02(17.27,20.77)
18months 21.91(20.03,23.80) 22.15(20.01,24.28) 20.79(19.04,22.55) 20.72(18.96,22.49)
WAIS-IIIMatrices Baseline 11.98(10.14,13.81) 13.24(11.31,15.17) 12.04(10.31,13.76) 11.53(99.81,13.25)
6months 11.82(9.97,13.67) 14.98(12.93,17.03) 13.26(11.54,14.98) 11.27(9.52,13.03)
18months 13.17(11.29,15.06) 14.16(11.97,16.35) 12.06(10.30,13.82) 11.65(9.88,13.42)
CategoryFluency Baseline 20.2(18.3,22.1) 18.3(16.3,20.2) 17.9(16.1,19.6) 18.4(16.7,20.2)
(AnimalNaming) 6months 20.5(18.6,22.4) 20.4(18.3,22.5) 18.2(16.5,20.0) 17.7(15.9,19.5)
18months 20.8(18.9,22.7) 21.3(19.1,23.5) 17.4(15.6,19.2) 17.5(15.7,19.3)
COWAT Baseline 38.24(33.34,43.14) 38.98(33.88,44.08) 36.40(31.79,41.01) 35.23(30.64,39.82)
6months 41.85(36.91,46.78) 43.28(37.92,48.64) 37.88(33.27,42.49) 41.09(36.43,45.74)
18months 42.71(37.71,47.72) 44.78(39.20,50.36) 39.22(34.54,43.89) 40.93(36.23,45.62)
ExecutiveFunctionDomain Baseline 0.066((cid:1)0.201,0.332) 0.080((cid:1)0.197,0.357) (cid:1)0.089((cid:1)0.340,0.162) (cid:1)0.169((cid:1)0.418,0.081)
6months 0.264((cid:1)0.004,0.532) 0.484(0.196,0.772) 0.096((cid:1)0.155,0.346) (cid:1)0.053((cid:1)0.305,0.199)
18months 0.392(0.122,0.663) 0.504(0.206,0.803) 0.026((cid:1)0.227,0.280) 0.034((cid:1)0.220,0.288)
Memory
ListLearningMemory Baseline 18.59(17.09,20.10) 20.96(19.40,22.53) 20.13(18.71,21.54) 18.84(17.43,20.25)
SumfromADAS-Cog 6months 19.72(18.20,21.24) 22.61(20.90,24.32) 20.79(19.38,22.21) 19.09(17.64,20.53)
18months 21.02(19.47,22.58) 22.42(20.64,24.10) 21.90(20.45,23.35) 20.91(19.45,22.37)
BVRT Baseline 5.98(5.31,6.65) 6.20(5.49,6.90) 5.86(5.23,6.49) 6.51(5.88,7.14)
6months 5.88(5.20,6.56) 6.15(5.38,6.93) 6.27(5.64,6.90) 5.46(4.81,6.11)
18months 6.57(5.87,7.27) 6.41(5.59),7.24) 6.12(5.47,6.77) 6.07(5.42,6.72)
LogicalMemoryI(immediate) Baseline 10.13(8.49,11.78) 10.17(8.34,12.00) 9.46(7.93,10.99) 9.60(8.04,11.16)
6months 10.61(8.98,12.24) 12.00(10.31,13.70) 10.42(8.89,11.95) 10.99(9.46,12.51)
18months 11.83(10.16,13.50) 13.03(11.16,14.89) 11.96(10.39,13.52) 11.00(9.44,12.56)
LogicalMemoryII(delayed) Baseline 8.17(6.32,10.12) 10.71(8.80,12.63) 8.71(6.98,10.48) 8.17(6.44,9.89)
6months 9.08(7.22,10.94) 8.62(6.58,10.66) 8.04(6.31,9.77) 7.75(6.00,9.51)
18months 10.20(8.32,12.08) 12.53(10.45,14.60) 10.23(8.47,11.99) 10.03(8.28,11.79)
MemoryDomain Baseline (cid:1)0.197((cid:1)0.488,0.094) 0.199((cid:1)0.104,0.501) (cid:1)0.108((cid:1)0.381,0.166) (cid:1)0.091((cid:1)0.363,0.182)
6months (cid:1)0.125((cid:1)0.418,0.168) 0.056((cid:1)0.264,0.376) (cid:1)0.107((cid:1)0.381,0.166) (cid:1)0.333((cid:1)0.610,(cid:1)0.056)
18months 0.231((cid:1)0.066,0.529) 0.531(0.196,0.865) 0.208((cid:1)0.070,0.486) 0.077((cid:1)0.202.0.357)
Attention/Speed
SDMT Baseline 45.58(41.43,49.73) 44.25(39.92,48.58) 44.94(41.05,48.83) 41.68(37.79,45.57)
6months 46.87(42.68,51.06) 46.29(41.66,50.92) 47.42(43.53,51.32) 44.11(40.15,48.07)
18months 46.40(42.21,50.59) 47.54(42.97,52.12) 47.55(43.63,51.47) 44.83(40.90,48.76)
Functionalstatus
BAYER-ADLscale* Baseline 0.3(0.2,0.3) 0.3(0.2,0.3) 0.2(0.2,03) 0.2(0.2,0.3)
6months 0.1(0.1,0.2) 0.2(0.1,0.2) 0.2(0.1,0.2) 0.1(0.1,0.2)
18months 0.1(0.1,0.2) 0.1(0.1,0.2) 0.2(0.1,0.2) 0.1(0.1,0.2)
n¼100foralloutcomes.AlldatawerenormallydistributedandrawdatausedexceptforBAYER-ADL,whichwasloggedpriortoanalyses.
Datarepresenttheestimatedmarginalmeansand95%confidenceintervals(CIs)fromrepeatedmeasureslinearmixedmodelsincludingall3timepoints,withfixedeffectsof
time,resistance,cognitive,andtheirinteractions,andadjustedforage,sex,andhighestlevelofeducation.
Domainresultsarecalculatedastheaverageofthez-scoresofthecomponenttests.
Z-scoreatbaseline¼individualvalueatbaselineminusmeanvalueforbaselinecohort/SDforbaselinecohort.
Z-scoreat6and18months¼individualvalueat6or18monthsminusmeanvalueforbaselinecohort/SDforbaselinecohort.
MemoryDomainwascalculatedbyaveragingthez-scoresofcomponentmemorytests:ADAS-CogListLearningMemorySum,LogicalMemoryI(immediate),LogicalMemory
II(delayed),andBVRT.
ExecutiveDomainwascalculatedbyaveragingthez-scoresofcomponentexecutivefunctiontests:WAIS-IIISimilarities,WAIS-IIIMatrices,COWAT,andCategoryFluency.
GlobalcognitionDomainwascalculatedbyaveragingthez-scoresofalltestsexceptADAS-CogMemorySum,asthisisasubscalewithintheADAS-Cogand,therefore,already
included.ThesignwasreversedontheADAS-Cogz-scoresothatpositivez-scorechangesindicateimprovementforalltestsandDomains.
*Lowerscoreindicatesbetterfunction;n¼numberoferrors(ADAS-Cog20)ormagnitudeofdeficitsinfunctionreportedbyinformant(BAYER-ADL21).Forallothertests,
higherscoreindicatesbetterfunction,n¼numbercorrect.
Discussion
Domainscoreat6months.Contrarytoourhypotheses,thetraining
andlong-termbenefitsofPRTaloneweresignificantlygreaterforboth
WehavereportedtheprimaryoutcomesofSMART,thefirstfully
globalandexecutivefunctioncomparedwithPRTcombinedwithCT.
factorialtrialofhighintensityPRTandcomputerizedmultidomainCT
inolderadultswithMCI.Ashypothesized,PRTsignificantlyimproved
EfficacyofResistanceTraining
measuresofglobalandexecutivefunctionaftertraining,aswellasat
18-monthfollow-up.CTdidnotimproveanyindividualtestresultat
Theclinicalrelevanceof thesignificantimprovementinourpri-
eithertimepoint,buttransientlyattenuateddeclineinoverallMemory
maryoutcomeofglobalfunction(ADAS-Cog)withPRTissupported
878 M.A.FiataroneSinghetal./JAMDA15(2014)873e880
Table2
RepeatedMeasuresLinearMixedModelAnalysisandRelativeEffectSizesforallOutcomes
StatisticalEffect TIME COGNITIVE(cid:4)TIME RESISTANCE(cid:4)TIME
PValue PValue RelativeEffectSize(95%CIs) PValue RelativeEffectSize(95%CIs)
GlobalFunction
ADAS-Cog*
Treatment(0,6) <.001 .66 0.07((cid:1)0.32,0.46) <.05 (cid:1)0.33((cid:1)0.73,0.06)
Long-term(0,6,18) <.001 .69 0.18((cid:1)0.21,0.57) .08 (cid:1)0.15((cid:1)0.55,0.24)
GlobalDomain
Treatment(0,6) <.001 .32 0.07((cid:1)0.17,0.30) .17 0.09((cid:1)0.50,0.32)
Long-term(0,6,18) <.001 .12 (cid:1)0.04((cid:1)0.27,0.19) .37 0.06((cid:1)0.17,0.29)
ExecutiveFunction
WAIS-IIISimilarities
Treatment(0,6) <.001 .89 0.02((cid:1)36,0.41) .77 0.05((cid:1)0.35,0.45)
Long-term(0,6,18) <.001 .84 (cid:1)0.07((cid:1)0.46,0.32) .39 (cid:1)0.18((cid:1)0.57,0.22)
WAIS-IIIMatrices
Treatment(0,6) .15 .79 (cid:1)0.05((cid:1)0.43,0.34) .06 0.37((cid:1)0.03,0.77)
Long-term(0,6,18) .27 .91 0.02((cid:1)0.37,0.41) <.02 (cid:1)0.04((cid:1)0.44,0.36)
CategoryFluency
Treatment(0,6) .17 .62 (cid:1)0.08((cid:1)0.47,0.31) <.06 0.32((cid:1)0.08,0.71)
Long-term(0,6,18) .37 .62 (cid:1)0.20((cid:1)0.59,0.19) .15 0.31((cid:1)0.09,0.71)
COWAT
Treatment(0,6) <.001 .14 (cid:1)0.20((cid:1)0.59,0.19) .29 (cid:1)0.15((cid:1)0.55,0.25)
Long-term(0,6,18) <.001 .31 (cid:1)0.17((cid:1)0.56,0.22) .48 (cid:1)0.06((cid:1)0.46,0.33)
ExecutiveDomain
Treatment(0,6) <.001 .39 (cid:1)0.07((cid:1)0.33,0.20) <.09 0.14((cid:1)0.13,0.40)
Long-term(0,6,18) <.001 .63 (cid:1)0.09((cid:1)0.36,0.17) <.07 0.01((cid:1)0.26,0.27)
MemoryFunction
ListLearningMemorySum
Treatment(0,6) .02 .95 (cid:1)0.01((cid:1)0.40,0.35) .53 0.12((cid:1)0.28,0.52)
Long-term(0,6,18) <.001 .88 0.09((cid:1)0.30,0.48) .33 (cid:1)0.17((cid:1)0.57,0.23)
BVRT
Treatment(0,6) .29 .06 0.41(0.01,0.80) .04 0.45(0.05,0.85)
Long-term(0,6,18) .13 .14 0.31((cid:1)0.08,0.70) <.06 0.10((cid:1)0.30,0.49)
ImmediateMemoryI
Treatment(0,6) .002 .23 0.21((cid:1)0.17,0.60) .55 0.12((cid:1)0.28,0.51)
Long-term(0,6,18) <.001 .28 0.21((cid:1)0.18,0.60) .47 0.28((cid:1)0.12,0.60)
DelayedMemoryII
Treatment(0,6) .12 <.06 0.29((cid:1)0.10,0.68) <.03 (cid:1)0.35((cid:1)0.75,0.05)
Long-term(0,6,18) <.001 .16 (cid:1)0.04((cid:1)0.43,0.35) .08 (cid:1)0.06((cid:1)0.46,0.33)
MemoryDomain
Treatment(0,6) .10 <.02 0.23((cid:1)0.06,0.52) .88 0.01((cid:1)0.28,0.30)
Long-term(0,6,18) <.001 <.08 0.12((cid:1)0.17,0.41) .98 0.03((cid:1)0.26,0.31)
Speed/Attention
SDMT
Treatment(0,6) .001 .84 (cid:1)0.03((cid:1)0.42,0.36) .89 0.04((cid:1)0.36,0.43)
Long-term(0,6,18) .001 .38 (cid:1)0.14((cid:1)0.53,0.25) .71 0.09((cid:1)0.30,0.49)
Functionalstatus
BAYER-ADL*
Treatment(0,6) <.001 .31 0.31((cid:1)0.09,0.70) .72 0.10((cid:1)0.30,0.50)
Long-term(0,6,18) <.001 .40 0.27((cid:1)0.12,0.66) .86 (cid:1)0.02((cid:1)0.41,0.38)
WAIS¼WechslerAdultIntelligenceScale;N¼100foralloutcomes.
AlldatawerenormallydistributedandrawdatausedinanalysesexceptforBAYER-ADL,whichwaslogged.
Domainscoresrepresenttheaverageofthez-scoresofeachcomponenttest.
Z-scoreatbaseline¼individualvalueatbaselineminusmeanvalueforbaselinecohort/SDforbaselinecohort.
Z-scoreat6and18months¼individualvalueat6or18monthsminusmeanvalueforbaselinecohort/SDforbaselinecohort.
MemoryDomainwascalculatedbyaveragingthez-scoresofcomponentmemorytests:ADAS-CogListLearningMemorySum,LogicalMemoryI(Immediate),LogicalMemory
II(Delayed),andBVRT.
ExecutiveDomainwascalculatedbyaveragingthez-scoresofcomponentexecutivefunctiontests:WAIS-IIISimilarities,WAIS-IIIMatrices,COWAT,andCategoryFluency.
GlobalCognitionDomainwascalculatedbyaveragingthez-scoresofalltestsexceptADAS-cogMemorySum,asthisisasubscalewithintheADAS-Cogand,therefore,already
included.ThesignwasreversedontheADAS-Cogz-scoresothatpositivez-scorechangesindicateimprovementforalltestsanddomains.
Twoseparaterepeatedmeasureslinearmixedmodelswereconstructedforeachcognitiveoutcome(dependentvariable).
Interventionfixedeffectsinmixedmodelswere:
RESISTANCE¼PRTandcombinedgroupsvsnoresistancetraining(CTandcontrolgroups)
COGNITIVE¼CTandcombinedgroupsvsnocognitivetraining(PRTandcontrolgroups)
Thefirstmodelincludedbaselineand6-monthdata(TreatmentEffect).Thesecondmodelincludedbaseline,6-and18-monthdata(Long-termEffect).Allmodelswere
adjustedforage,sexandhighesteducationallevelachievedandincludedmaineffectsofTIME,RESISTANCE,COGNITIVE,andtheinteractionterms:RESISTANCE(cid:4)TIME,
COGNITIVE(cid:4)TIME,ANDRESISTANCE(cid:4)COGNITIVE(cid:4)TIME.
PvaluesarefromthemixedmodelTypeIIISumofSquarestestsofthesefixedeffects.
RelativeHedges’BiasCorrectedEffectSizes(ES)and95%CI40werecalculatedforeachtimepointandmaintreatmenteffectsforeachcognitiveoutcomeusingtheestimated
marginalmeansandstandarddeviations(SD)fromthemixedmodels:
Relativeeffectsize(ES)¼(post-testminusBaseline)INTERVENTIONe(Post-testminusBaseline)NOINTERVENTION/pooledbaselineSDofcohort.
ForthedomainESs,whicharealreadystandardizedz-scores,theformulawas:
RelativeES¼post-testdomainz-scoreminusbaselinez-score(95%CIs).
*Lowerscoreindicatesbetterfunction,n¼numberoferrorsontheADAS-Cog20ormagnitudeofdeficitsinfunctionbyinformantontheBAYER-ADLscale.21Forallother
tests,higherscoreindicatesbetterfunction,n¼numbercorrect.
M.A.FiataroneSinghetal./JAMDA15(2014)873e880 879
A
B
Fig.2. ProportionofparticipantswithADAS-Cogtotalscorewithinnormalrangeat
baselineandafter6monthsoftraining.*Resistancetrainingwasassociatedwitha
significantly increased proportion of participants with normal ADAS-Cog scores
(increasingfrom24%atbaselineto48%aftertrainingcomparedwith20%to27%inthe
nonresistancetrainingparticipants:adjustedOR(95%CIs)¼3.50(1.18,10.48),P<.03).
Bycontrast,therewasnosignificanteffectofCTonADAS-Cogstatusat6months
(increasingfrom29%to48%normal)comparedwithnoncognitivetrainingparticipants
(increasingfrom14%to27%normal;OR1.00(0.34,2.95;P>.99).
bytheobserveddoublingofthenumberofindividualsscoringwithin
thenormalrangeofADAS-Cog(absoluteincreasefrom24%to48%of
participants),aswellasbythepersistenceofbenefitforexecutiveand Fig.3. ChangesinExecutiveandGlobalDomainscoresat18monthsbyrandomization
group.Datarepresentthe18-monthz-scorechangeandstandarderrorforeachgroup.
globalfunctioneven12monthsaftercessationofsupervisedtraining. COMBINED¼PRTþCT;CONTROL¼shamcognitiveandshamexercise.Greaterz-
Prior systematic reviews and meta-analyses of exercise and scorechangesindicatemoreimprovement.A,ExecutiveDomainchangesat18months.
cognitionhavemainlyfocusedonaerobicexerciseandlinkeditmost The PRT Group improvement was significantly greater than the Combined Group
closelytoimprovedexecutivefunctioninhealthyolderadults.10,26,27 improvement(*P¼.02).Noothercomparisonsweresignificant(P>.05).B,Global
Bycontrast,inourrecentreviewofRCTsspecifictoindividualswith
Domainchangesat18months.ThePRTGroupimprovementwassignificantlygreater
thantheCombinedGroupimprovement(**P<.04).Noothercomparisonsweresig-
MCI,11thebenefitofaerobicexercisewaslimitedtoverbalfluency(no
nificant(P>.05).
other executive function), and did not benefit memory in any
trial.18,28e31
Furthermore, the 2 trials of isolated moderate-high in-
tensity resistance training resulted in large significant effects on significantly worse compared with isolated PRT on Executive and
memory,17,18whereastheeffectoflowerintensityresistancetraining
GlobalDomains;differenceswhichweresustainedat18months.This
combined with other exercise modalities was
inconclusive.32e35
paradoxicalnegativeeffectofcombinedphysicalandCTweobserved
Thesepriorsystematicreviews,alongwiththecurrentSMARTfind-
standsincontrasttolargebeneficialeffectsreportedintwoprevious
ingsofsignificantlyimprovedglobalfunction,executivefunction,and
smallstudiesofcombinedphysical/CTinhealthycohorts,37,38aswell
verbal/constructivememoryinMCIafterPRTprovideevidenceofthe
astotheneutraleffectseenintherecentMentalActivityandeXercise
utilityof this specific exercise modalityat highintensity toaddress (MAX)36trialinolderadultswithcognitivecomplaints.
cognitivedeclineinthiscohort. ThemechanismofthissignificantbluntingofPRTbenefitwhenCT
wasaddedisnotknown.Thecombinedintervention,whichwasboth
EfficacyofCT
mentallyandphysicallychallenging,couldhaveresultedinexcessive
stress, less engagement in home or community-based activities, or
CT prevented objective memory decline during the intervention otherchangesthat inhibited rather thanpromoted neural plasticity
period only, suggesting that the benefits fromCT in this cohort are andcognitivebenefits.Concurrentaerobicandresistiveexercisehas
contingentuponsustainedtraining.VeryfewRCTsofmultidomainCT beenshowntonegativelyimpactanabolicadaptationstoisolatedPRT
suchasusedinSMARThavebeenreportedinindividualswithMCI12or
suchasstrengthgain,thoughttobeduetointerferenceatthemo-
cognitive complaints,36 and the results are mixed, with most effect lecularlevel.39It ispossiblethat asimilarinterferencewithneural/
sizesbeingnegligibleorsmall.Thus,ourfindingsandreviewofthe
cognitiveadaptationstoPRTcouldoccurwithconcurrentCT,anovel
literaturesuggestthatthereiscurrentlynoevidence-basedCTtraining hypothesiswarrantingfurtherinvestigation.
paradigmtorecommendforglobalcognitiveimprovementinMCI.
Conclusions
CombinedPRTandCT
Wehaveshownforthefirsttimethat6monthsofhighintensity
Contrary to our hypothesis, the Combined Training Group, PRT improved the primary outcome of global cognition, as well as
receiving full doses of each active intervention, performed executivefunctionandverbal/constructionalmemoryinolderadults
880 M.A.FiataroneSinghetal./JAMDA15(2014)873e880
with MCI, with somemaintenance of global and executive function 13. Cotman CW, Berchtold NC, Christie L. Exercise builds brain health. Trends
benefit12monthsaftercessationoftraining.Bycontrast,CThadno Neurosci2007;30:464e472.
significanteffectsonglobalfunction,individualtests,oranyCognitive 14. Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive
reserve:Mentalandphysicalactivityasmodulatorsofbraindisorders.Prog
Domains other than memory, and it attenuated Memory Domain Neurobiol2009;89:369e382.
declineduringtheperiodofactivetrainingonly.CombinedTraining 15. NourhashemiF,AndrieuS,Gillette-GuyonnetS,etal.Istherearelationship
unexpectedly significantly reduced the benefits of isolated PRT on betweenfat-freesofttissuemassandlowcognitivefunction?Resultsfroma
studyof7105women.JAmGeriatrSoc2002;50:1796e1801.
executiveandglobalfunction.Furtherlarge-scaletrialsarewarranted 16. BurnsJM,JohnsonDK,WattsA,etal.ReducedleanmassinearlyAlzheimer
to confirm and extend our findings, explore the mechanism of disease and its association with brain atrophy. Arch Neurol 2010;67:
cognitive/neural adaptations to PRT, and most critically to demon-
428e433.
17. BusseAL,FilhoWJ,MagaldiRM,etal.Effectsofresistancetrainingexerciseon
stratethatPRTcanreduceincidentdementiainthishigh-riskcohort. cognitiveperformanceinelderlyindividulaswithmemoryimpairment:Re-
sultsofacontrolledtrial.Einstein2008;6:402e407.
18. NagamatsuLS,HandyTC,HsuCL,etal.Resistancetrainingpromotescognitive
Acknowledgments and functional brain plasticity in seniors with probable mild cognitive
impairment.ArchNeurol2012;172:666e668.
TheauthorswouldliketothankMs.BrookeMcMahonforassis- 19. GatesN,ValenzuelaM,SachdevP,etal.Studyofmentalactivityandregular
training (SMART) in at risk individuals: A randomised double blind, sham
tancewithrecruitmentandtraining,Ms.DominiqueWilliamson,Dr.
controlled,longitudinaltrial.BMCGeriatr2011;11:19.
ShelleyKaye,andDr.AngelaWrightforassistancewithassessments, 20. RosenWG,MohsRC,DavisKL.AnewratingscaleforAlzheimer’sdisease.AmJ
Mr.BradLloydandDr.AngelaWrightfortheirassistancewithManual Psychiatry1984;141:1356e1365.
21. HindmarchI,LehfeldH,deJonghP,ErzigkeitH.Thebayeractivitiesofdaily
ofProcedurespreparation,Ms.KateBradshawforherassistancewith Livingscale(B-ADL).DementGeriatrCognDisord1998;9:20e26.
recruitment,andDr.JohnCrawfordforhisassistancewithstatistical 22. Petersen RC, Smith GM, Ivnik RJ, et al. Mild cognitive impairment:clinical
analyses. All acknowledged individuals have provided written con- characterisationandoutcome.ArchNeurol1999;56:303e308.
23. MarkerKR.(1986-2008)MarkerSoftware.HeidelbergandLadenburg.
sent for their acknowledgement. Donations for participant rewards
24. GreenawayMC,HannaSM,LeporeSW,SmithGE.Abehavioralrehabilitation
were received from Gregory and Carr Funerals. The authors would intervention for amnestic mild cognitive impairment. Am J Alzheimers Dis
also like to thank the extraordinary generosity and commitment of OtherDemen2008;23:451e461.
25. WechslerD.WechslerMemoryScale,3rded.In:CorporationTP,ed.SanDiego,
the participants and their families who devoted their time and
CA:HarcourtBraceandCompany;1997.
continuetoparticipateintheSMARTstudy. 26. BarberS,CleggAP,YoungJB.Istherearoleforphysicalexerciseinpreventing
declineinpeoplewithmildcognitiveimpairment?AgeAgeing2012;41:5e8.
27. Smith P, Blumenthal JA, Hoffman BM, et al. Aerobic exercise and neuro-
SupplementaryData cognitiveperformance:Ameta-analyticreviewofrandomisedcontrolledtrials.
PsychosomMed2010;72:239e252.
SupplementaryDatarelatedtothisarticlecanbefoundonlineat 28. VanUffelenJGZ,ChinapawMJM,VanMechelenW.WalkingorvitaminBfor
cognition in older adults with mild cognitive impairment? A randomized
http://dx.doi.org/10.1016/j.jamda.2014.09.010. controlledtrial.BrJSportsMed2008;42:344e351.
29. BakerLD,FrankLL,Foster-SchubertK,etal.Effectsofaerobicexerciseonmild
cognitiveimpairment.ArchNeurol2010;67:71e79.
References
30. ScherderEJA,VanPaasshenJ,DeijenJ-B,etal.Physicalactivityandexecutive
functionsintheelderlywithmildcognitiveimpairment.AgingMentalHealth
1. PrinceM,BryceaR,AlbanesebE,etal.Theglobalprevalenceofdementia:A 2005;9:272e280.
systematicreviewandmetaanalysis.AlzheimersDement2013;9:63e75. 31. Lautenschlager NT, Cox K, Flicker L, et al. Effects of physical activity on
2. PetersenRC,RobertsRO,KnopmanDS,etal.Mildcognitiveimpairment.Arch cognitivefunctioninolderadultsatriskforAlzheimerdisease.JAMA2008;
Neurol2009;66:1447e1455. 300:1027e1037.
3. LehrnerJ,GuflerR,GuttmannG,etal.AnnualconversiontoAlzheimerdisease 32. WilliamsonJD,EspelandM,KritchevskySB,etal.Changesincognitivefunction
among patients with memory complaints attending an outpatient memory inarandomizedtrialofphysicalactivity:Resultsofthelifestyleinterventions
clinic:Theinfluenceofamnesticmildcognitiveimpairmentandthepredictive and independence for elders pilot study. J Gerontol Med Sci 2009;64A:
value of neuropsychological testing. Wiener Klinische Wochenschrift 2005; 688e694.
117:629e635. 33. BrownAK,Liu-AmbroseT,TateR,LordSR.Theeffectofgroup-basedexercise
4. Kaduszkiewicz H, Zimmerman T, Beck-Bornholdt H, van der Bussche H. oncognitiveperformanceandmoodinseniorsresidinginintermediatecare
Cholinesterase inhibitors for patients with Alzheimer’s disease: Systematic andself-careretirementfacilities:Arandomisedcontrolledtrial.BrJSports
reviewofrandomisedclinicaltrails.BMJ2005;331:321e327. Med2009;43:608e614.
5. BarnesDE,YaffeK.TheprojectedeffectofriskfactorreductiononAlzheimer’s 34. KimuraK,ObuchiS,AraiT,etal.Theinfluenceofshort-termstrengthtraining
diseaseprevalence.LancetNeurol2011;10:819e828. on health related quality of life and executive cognitive function. J Physiol
6. ValenzuelaMJ.Brainreserveandthepreventionofdementia.CurrOpinPsy- Anthropol2010;3:95e101.
chiatry2008;21:296e302. 35. Molloy DW, Delaquerriere Richardson L, Crilly RG. The effects of a three-
7. CotmanCW,BerchtoldNC.Exercise:Abehaviouralinterventiontoenhance monthexerciseprogrammeonneuropsychologicalfunctioninelderlyinsti-
brainhealthandplasticity.TrendsNeurosci2002;25:295e301. tutionalized women: a randomized controlled trial. Age Ageing 1988;17:
8. HeynPC,JohnsonKE,KramerAF.Enduranceandstrengthtrainingoutcomeson 303e310.
cognitivelyimpairedandcognitivelyintactolderadults:Ameta-analysis.JNutr 36. BarnesDE,Santos-ModesittW,PoelkeG,etal.ThementalactivityandeXercise
HealthAging2008;12:401e409. (MAX)trial:Arandomizedcontrolledtrialtoenhancecognitivefunctionin
9. Valenzuela MJ, Sachdev P. Brain reserve and cognitive decline: A nonpara- olderadults.JAMAInternMed2013;173:797e804.
metricsystematicreview.PsycholMed2006b;36:1065e1073. 37. FabreC,ChamariK,MucciP.Improvementofcognitivefunctionviamental
10. Colcombe SJ, Kramer AF. Fitness effects on the cognitive function of older and/orindividualisedaerobictraininginhealthyelderlysubjects.IntJSports
adults:Ameta-analyticstudy.AmPsycholSoc2003;14:125e130. Med2002;23:415e421.
11. GatesN,FiataroneSinghMA,SachdevPS,etal.Theeffectofexercisetraining 38. OswaldW,GunzelmannT,RupprechtR.Differentialeffectsofsingleversus
oncognitivefunctioninolderadultswithmildcognitiveimpairment:Ameta- combinedcognitiveandphysicaltrainingwitholderadults:TheSimAstudyin
analysis of randomized controlled trials. Am J Geriatr Psychiatry 2013;21: a5-yearperspective.EurJAgeing2006;3:179e192.
1086e1097. 39. Nader GA. Concurrent strength and endurance training: From molecules to
12. Gates NJ, Sachdev PS, Fiatarone Singh MA, Valenzuela MJ. Cognitive and man.MedSciSportsExerc2006;38:1965e1970.
memory training in adults at risk of dementia: A systematic review. BMC 40. CoeR.Effectsizecalculator:Aguidetousingthespreadsheet.Availableat:
Geriatr2011;11:55. http://www.cem.org/effect-size-calculator.AccessedOctober17,2014.
